Purpura Schoenlein-Henoch - Results of the Wörlitz 2005 Consensus Conference focussing on diagnosis and therapy;Purpura Schoenlein-Henoch - Ergebnisse der Wörlitzer Konsensusgespräche 2005 zum diagnostischen und therapeutischen vorgehen

Klinische Padiatrie

Volumn 220, Issue 1, 2008, Pages 47-52

  Hospach, T ^a   Klaus, G ^b   Holl Ulrich, K ^c   Dannecker, G E ^a   Horneff, G ^d  

^a OLGAHOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Asklepios Klinik Sankt Augustin   (Germany)

Author keywords

Diagnosis; Purpura; Schoenlein Henoch; Therapy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE; STEROID;

ANAPHYLACTOID PURPURA; BIOPSY; CLINICAL FEATURE; CONFERENCE PAPER; CONSENSUS; DIFFERENTIAL DIAGNOSIS; HUMAN; INTESTINE; JOINT; LABORATORY TEST; NEPHRITIS; PATHOLOGY; PLASMAPHERESIS; PROGNOSIS; PROPHYLAXIS; SKIN; TREATMENT INDICATION; ADOLESCENT; AGE; ARTICLE; CHILD; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; ECHOGRAPHY; FOLLOW UP; GERMANY; HOSPITALIZATION; INFANT; KIDNEY; NEWBORN; RADIOGRAPHY; TIME;

ADOLESCENT; AGE FACTORS; BIOPSY; CHILD; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; GERMANY; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; NEPHRITIS; PROGNOSIS; PURPURA, SCHOENLEIN-HENOCH; SKIN; TIME FACTORS;

EID: 40949144053     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-972570     Document Type: Conference Paper

References (51)

1. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schoenlein-Henoch syndrome): review with follow-up ot the renal complications. Am J Dis Child 1960; 99: 833-854
2. Caksen H, Odabas D, Kösem M, Arslan S, Öner AF, Atas B, Akcay G, Ceylan N. Report of eight infants with acute infantile hemorrhagic edema and review of the literature. J Dermatol 2002; 29: 290-295
3. Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch-Schonlein purpura: a 10-year clinical study. Pediatr Nephrol 2005; 20: 1269-1272 . Epub 2005 Jun 10
4. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993-1003
5. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura. Nephrol Dial Transplant 1997; 12: 2277-2283
6. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C. Prognosis of Henoch-Schonlein nephritis in children. Br Med J 1977; 2: 11-14
7. Dixit MP, Dixit NM, Scott K. Managing Henoch-Schonlein purpura in children with fish oil and ACE inhibitor therapy. Nephrology (Carlton) 2004; 9: 381-386
8. Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 2000; 136: 370-375
9. Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002; 32: 149-156
10. Gardner-Medwin JMM, Dolezalova P, Cummings C, Southwood TR. Incidence of Henoch-Schoenlein purupura, Kawasaki disease and rare vasculitides in children of different ethnic origins. Lancet 2002; 360: 1197-1202
11. Glasier CM, Siegel MJ, MacAlister WH, Shackelford GD. Henoch-Schonlein syndrome in children: gastrointestinal manifestations. Am J Roentgenol 198; 6: 1081-10855
12. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 1992; 339: 280-282
13. Halling SF, Soderberg MP, Berg UB. Henoch Schonlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol 2005; 20: 46-51 . Epub 2004 Oct 22
14. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999; 33: 427-433
15. Hospach T, Dannecker GE. Purpura Schoenlein-Henoch In: Evidenzbasierte Pädiatrie Thieme Verlag. EG I 2004
16. Huber AM, King J, MacLaine P, Klassen T, Pothos M. A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. BMC Med 2004; 2: 7
17. Hung SH, Yang YH, Lee CC, Wang LC, Lin YT, Chiang BL. Clinical predictors of self-limited urinalysis abnormality in childhood Henoch-Schonlein purpura nephritis. Acta Paediatr 2006; 95: 306-311
18. Prenzel F, Pfäffle R, Thiele F, Schuster V. Decreased Factor XIII Activity during Severe Henoch-Schoenlein Purpura - Does It Play a Role? Klin Pädiatr 2006; 218: 174-176
19. Kawana S, Shen GH, Kobayashi Y, Nishiyama S. Membrane attack complex of complements in Henoch-Schonlein Purpura skin and nephritis. Arch Dermatol Res 1990; 282: 183-187
20. Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, Suzuki S, Suzuki H. Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol 2004; 19: 920-923 . Epub 2004 Jun 9
21. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 2003; 111: 785-789
22. Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, Suzuki H. Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 2003; 60: 153-160
23. Kawasaki Y, Suzuki J, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 2004; 19: 858-864
24. Ladell K. Was ist Leukoyzytoklasie? Eine histologische und elektronenmikroskopische Untersuchung an kutaner leukozytoklastischer Vaskulitis. Dissertation 2001; http://edoc.hu-berlin.de/dissertationen/ladell- krstin-2001-05-25/HTML/front.htmlfront
25. Mills JA, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schoenlein purpura. Arth Rheum 1990; 33: 1114-1121
26. Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM. Leukocytoclastic Vasculitis associated with tumor necrosis factors blocking agents. J Rheumatol 2004; 31: 1955-1958
27. Mollica F, Li Volti S, Garozzo R, Russo G. Corticosteroid therapy does not prevent nephritis in Henoch-Schonlein purpura. Pediatr Nephrol 1994; 8: 131
28. Mrusek S, Krüger M, Greiner P, Kleinschmidt M, Brandis M, Ehl S. Henoch-Schoenlein purpura. Lancet 2004; 363: 1116-1116
29. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: A systematic review. Arch Dis Child 2005; 90: 916-920 . Epub 2005 May 4
30. Niaudet P, Habib R. Schonlein-Henoch purpura nephritis: prognostic factors and therapy. Ann Med Interne (Paris) 1994; 145: 577-580
31. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatr Nephrol 1998; 12: 238-243
32. Niaudet P, Levy M, Broyer M, Habib R. Clinicopathologic correlations in severe forms of Henoch-Schonlein purpura nephritis based on repeat biopsies. Contrib Nephrol 1984; 40: 250-254
33. Ozen S, et al. EULAR/PRES endorsed Consensus Criteria for the Classification of Childhood Vasculitides under review by the ACR: Ann Rheum Dis published online 1 Dec. 2005, doi:10.1136/ ard.2005.046300
34. Ozen S. The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol 2002; 3: 411-425
35. Prigent F, Chevalier B, Bensman A et al. L'alitement, traitment du purpura rhumatoide? Ann Dermatol Venereol 1997; 124: 296-298
36. Reinehr T, Bürk G, Andler W. Does steroid treatment of abdominal pain prevent renal involvement in Henoch-Schoenlein purpura. J Pediatr Gastroenterol Nutr 2000; 3: 323-324
37. Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormala T, Nuutinen M. Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003; 60: 80-84
38. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 2002; 360: 666-670
39. Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinenen J, Nuutinen M. Early prednisone therapy in Henoch-Schonlein purpura: a randomise, double-blind, placebo-controlled trial. J Pediatr 2006; 149: 241-247
40. Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in Henoch-Schoenlein purpura. Pediatrics 1987; 79: 1081-1021
41. Rostoker G. Schoenlein-Henoch Purpura in children and adults. Bio-Drugs 2001; 2: 99-138
42. Sams WM. Hypersensitivity angiitis. J Invest Dermatol 1989; 93: 78-81
43. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Schonlein purpura. Pediatr Nephrol 1993; 7: 69-71
44. Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999; 13: 816-823
45. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571-590
46. Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol 2006; 35: 56-60
47. Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, Jeong HJ. Cyclosporin A therapy for severe Henoch-Schonlein nephritis with nephritic syndrome. Pediatr Nephrol 2005; 20: 1093-1097 . Epub 2005 Jun 10
48. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ. Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol 2005; 20: 1087-1092 . Epub 2005 May 12
49. Tizard EJ. Henoch-Schoenlein purpura. Arch Dis Child 1999; 80: 380-383
50. White RHR. Schoenlein Henoch Purpura In Churg A, Churg J (eds). Systemic vasculitides. New York: Igaku-Shoin 1991; 201-217
51. Yarvuz H, Arslan A. Henoch-Schoenlein purura-related intestinal perforation: a steroid complication? Pediatr Int 2001; 43: 423-425